| Description | Crefmirlimab (89Zr-Df-IAB22M2C) is an anti-CD8 probe designed for the diagnosis of diverse cancers, targeting the CD8 antigen. |
| Synonyms | 89Zr-Df-IAB22M2C |
| molecular weight | N/A |
| CAS | 2611099-93-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |